Oncotelic Therapeutics, Inc. (OTLC)
0.0465
0.00 (0.00%)
USD |
OTCM |
Feb 20, 16:00
Oncotelic Therapeutics EPS Diluted (Quarterly) : -0.0025 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.098 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Eli Lilly & Co. | 7.024 |
| Merck & Co., Inc. | 1.191 |
| Supernus Pharmaceuticals, Inc. | -0.7978 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.114M |
| Total Expenses (Quarterly) | 1.047M |
| Enterprise Value | 33.72M |
| Earnings Yield | -8.82% |
| Normalized Earnings Yield | -7.097 |